Increasing incidence of post-kala-azar dermal leishmaniasis in a population-based study in Bangladesh

KM Rahman, S Islam, MW Rahman… - Clinical Infectious …, 2010 - academic.oup.com
Post–kala-azar dermal leishmaniasis (PKDL) occurs after kala-azar treatment and acts as a
durable infection reservoir. On the basis of active case finding among 22,699 respondents …

Intermediate or chronic cutaneous leishmaniasis: leukocyte immunophenotypes and cytokine characterisation of the lesion

NL Diaz, O Zerpa, LV Ponce, J Convit… - Experimental …, 2002 - Wiley Online Library
The American cutaneous forms of leishmaniasis include immune‐responder individuals with
localised cutaneous leishmaniasis (LCL) and non‐responder individuals with diffuse …

Cutaneous leishmaniasis: the complexity of host's effective immune response against a polymorphic parasitic disease

Á Gabriel, A Valério-Bolas… - Journal of …, 2019 - Wiley Online Library
This review is aimed at providing a comprehensive outline of the immune response
displayed against cutaneous leishmaniasis (CL), the more common zoonotic infection …

Post-kala-azar dermal leishmaniasis and leprosy: case report and literature review

MAB Trindade, LLC Silva, LMA Braz, VS Amato… - BMC infectious …, 2015 - Springer
Background Post-kala-azar dermal leishmaniasis (PKDL) is a dermal complication of
visceral leishmaniasis (VL), which may occur after or during treatment. It has been frequently …

Post-kala-azar dermal leishmaniasis

EE Zijlstra, AM Musa, EAG Khalil… - The Lancet infectious …, 2003 - thelancet.com
Post-kala-azar dermal leishmaniasis (PKDL) is a complication of visceral leishmaniasis (VL);
it is characterised by a macular, maculopapular, and nodular rash in a patient who has …

Post-kala-azar dermal leishmaniasis–an appraisal.

V Ramesh, R Singh, P Salotra - Tropical Medicine & …, 2007 - search.ebscohost.com
Short communication: Post-kala-azar dermal leishmaniasis – an appraisal Page 1 Short
communication: Post-kala-azar dermal leishmaniasis – an appraisal V. Ramesh, Ruchi Singh …

Evaluation of enzyme-linked immunosorbent assay for diagnosis of post-kala-azar dermal leishmaniasis with crude or recombinant k39 antigen

P Salotra, G Sreenivas, AA Nasim… - Clinical and Vaccine …, 2002 - Am Soc Microbiol
The diagnosis of post-kala-azar dermal leishmaniasis (PKDL), a dermatosis that provides
the only known reservoir for the parasite Leishmania donovani in India, remains a problem …

Safety and immunogenicity of ChAd63-KH vaccine in post-kala-azar dermal leishmaniasis patients in Sudan

BM Younis, M Osman, EAG Khalil, F Santoro, S Furini… - Molecular therapy, 2021 - cell.com
Post-kala-azar dermal leishmaniasis (PKDL) is a chronic, stigmatizing skin condition
occurring frequently after apparent clinical cure from visceral leishmaniasis. Given an urgent …

Laboratory diagnosis of visceral leishmaniasis

S Sundar, M Rai - Clinical and vaccine immunology, 2002 - Am Soc Microbiol
The group of diseases known as the leishmaniases are caused by obligate intracellular
protozoa of the genus Leishmania (39). Natural transmission of leishmania is carried out by …

Clinico-epidemiological analysis of Post kala-azar dermal leishmaniasis (PKDL) cases in India over last two decades: a hospital based retrospective study

V Ramesh, H Kaushal, AK Mishra, R Singh, P Salotra - BMC public health, 2015 - Springer
Abstract Background Patients with Post kala-azar dermal leishmaniasis (PKDL) are
considered a reservoir of Leishmania donovani. It is imperative to identify and treat them …